| Ms Teresa Elizabeth Dixon, SLP | |
|
601 Yorktown Manor Ct, Annapolis, MD 21409-5767 | |
| (443) 758-3240 | |
| Not Available |
| Full Name | Ms Teresa Elizabeth Dixon |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 601 Yorktown Manor Ct, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932327400 | NPI | - | NPPES |
| 1009052600002 | Medicaid | PA |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Teresa Elizabeth Dixon, SLP 601 Yorktown Manor Ct, Annapolis, MD 21409-5767 Ph: (443) 758-3240 | Ms Teresa Elizabeth Dixon, SLP 601 Yorktown Manor Ct, Annapolis, MD 21409-5767 Ph: (443) 758-3240 |
News Archive
Two recent, separate publications identified regions with higher than expected numbers of autism cases - or clusters - in California. Using data collected by the California Department of Developmental Services (DDS) on 2.5 million births including almost 10,000 autism cases from 1996-2000, investigators at UC Davis uncovered several clusters of elevated risk for autism.
VentriPoint Diagnostics Ltd. today announced the abstract of a clinical validation study of the second application of the VentriPoint Medical System (VMS) will be presented at the American College of Cardiology's 59th Annual Scientific Session, March 14 to 16 in Atlanta, Georgia. The study demonstrates the accuracy of the method used by the VentriPoint Medical System (VMS) to generate critical heart measurements in three dimensions from two-dimensional ultrasound images with significantly greater speed and accuracy and at considerably lesser cost than is otherwise possible.
Issues surrounding gender identity in young children who are transgender or gender non-conforming are poorly understood because of the limited amount of research in this area.
The U.S. Food and Drug Administration (FDA), working in close coordination with the U.S. Department of Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered into a plea agreement in which the company accepted responsibility for criminal actions including distribution of an unapproved new drug, distribution of a misbranded drug, and obstruction of an FDA inspection.
› Verified 6 days ago
Fran L Silverman, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Anne Caverly, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Taylor Falatach, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Williams Dr, Annapolis, MD 21401 Phone: 609-519-1954 | |
Mrs. Betty Chan-brown, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 190 Admiral Cochrane Dr, Suite 180, Annapolis, MD 21401 Phone: 410-571-6411 Fax: 410-571-6415 | |
Mrs. Judith Ann Wildner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 | |
Rajavi Sanghavi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 900 Van Buren St, Annapolis, MD 21403 Phone: 410-267-8653 Fax: 877-828-2060 | |
Victoria Washington-harper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000 |